Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GAP

Pharmagap Inc. (GAP)

Pharmagap Inc.
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:GAP
DateTimeSourceHeadlineSymbolCompany
3:00PMiHub NewswireFeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements
05/07/201310:26AMPR Newswire (Canada)PharmaGap Notified of Cease Trade OrderTSXV:GAPPharmagap Inc.
05/06/20132:47PMPR Newswire (Canada)TSX Venture Exchange Cease Trade OrderTSXV:GAPPharmagap Inc.
05/06/20138:20AMPR Newswire (Canada)IIROC Trading Halt - GAPTSXV:GAPPharmagap Inc.
05/06/20138:20AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - GAPTSXV:GAPPharmagap Inc.
02/06/20138:00AMPR Newswire (Canada)PharmaGap Receives Notice of Pending Transfer to NEX ExchangeTSXV:GAPPharmagap Inc.
02/04/201311:11AMPR Newswire (Canada)L’OCRCVM permet la reprise de la négociation - GAPTSXV:GAPPharmagap Inc.
02/04/201311:11AMPR Newswire (Canada)IIROC Trading Resumption - GAPTSXV:GAPPharmagap Inc.
02/04/201310:32AMPR Newswire (Canada)PharmaGap Provides Update on StatusTSXV:GAPPharmagap Inc.
02/04/20139:11AMPR Newswire (Canada)IIROC Trading Halt - GAPTSXV:GAPPharmagap Inc.
02/04/20139:11AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - GAPTSXV:GAPPharmagap Inc.
08/02/20127:03AMPR Newswire (Canada)PharmaGap Shareholders Approve License to Clinical Value Corporation at Annual General MeetingTSXV:GAPPharmagap Inc.
07/05/20128:00AMPR Newswire (Canada)PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value CorporTSXV:GAPPharmagap Inc.
06/05/20128:30AMPR Newswire (Canada)PharmaGap Updates Lead Drug Status and Potential SaleTSXV:GAPPharmagap Inc.
05/24/20128:30AMPR Newswire (Canada)PharmaGap announces conditional approval to license its lead drug and related intellectual propertyTSXV:GAPPharmagap Inc.
01/20/20123:19PMMarketwired CanadaPharmaGap Completes $231,000 Private PlacementTSXV:GAPPharmagap Inc.
01/11/20123:21PMMarketwired CanadaPharmaGap Completes $70,774 Private PlacementTSXV:GAPPharmagap Inc.
12/21/20117:00AMMarketwired CanadaPharmaGap Completes In Vivo Study Protocol in Ovarian CancerTSXV:GAPPharmagap Inc.
12/05/20117:00AMMarketwired CanadaPharmaGap Completes $634,210 Private PlacementTSXV:GAPPharmagap Inc.
11/28/20113:48PMMarketwiredPharmaGap Completes Initial Closing of Private PlacementTSXV:GAPPharmagap Inc.
11/25/20118:00AMMarketwiredPharmaGap Liposomal Formulations Achieve Key Milestones for Clinical TrialsTSXV:GAPPharmagap Inc.
11/15/20118:00AMMarketwiredPharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical TrialsTSXV:GAPPharmagap Inc.
10/27/20118:00AMMarketwiredPharmaGap Sets Time for in Vivo TestsTSXV:GAPPharmagap Inc.
10/24/20118:00AMMarketwiredPharmaGap Chooses Ovarian Cancer as Target for First Clinical TrialsTSXV:GAPPharmagap Inc.
10/21/20114:00PMMarketwiredPharmaGap Completes Placement of Equity UnitsTSXV:GAPPharmagap Inc.
10/21/20114:00PMMarketwired CanadaPharmaGap Completes Placement of Equity UnitsTSXV:GAPPharmagap Inc.
10/19/20118:00AMMarketwiredPharmaGap Completes Manufacturer Site Audits Required for Clinical Trial SubmissionTSXV:GAPPharmagap Inc.
10/03/20118:38AMMarketwiredPharmaGap Files Provisional Patent Application for Liposomal Formulations of GAP-107B8TSXV:GAPPharmagap Inc.
09/30/201110:00AMMarketwiredPharmaGap to Host Investor Conference CallTSXV:GAPPharmagap Inc.
09/29/20118:43AMMarketwiredPharmaGap Adds to Patent Portfolio For GAP-107B8 Cancer Drug; Expands ClaimsTSXV:GAPPharmagap Inc.
 Showing the most relevant articles for your search:TSXV:GAP

Your Recent History

Delayed Upgrade Clock